4
Changes in Ownership
Mirum Pharmaceuticals, Inc. Filed Acc 0001209191-23-027549
Director sold 14,608 shares at $28.00 ($409,024)
- Director acquired 14,608 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
GREY MICHAEL G · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-05-03 | Exercise or conversion : show line 1 in the form 10b5-1 | +14,608 | $2.94 | $42,889 | 14,608 | D |
| 2023-05-03 | Sale : show line 2 in the form 10b5-1 | −14,608 | $28.00 | $409,024 | 0 | D |
| Open-market sales · 14,608 sh · avg $28.00 · $409,024 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-05-03 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (right to buy) | −14,608 | 360,392 | D |
Loading xslF345X04/doc4.xml…